[1]陈智红,成官迅.心脏磁共振定量成像评价心肌疾病的应用[J].医学信息,2019,32(08):8-13.[doi:10.3969/j.issn.1006-1959.2019.08.003]
　CHEN Zhi-hong,CHENG Guan-xun.Application of Cardiac Magnetic Resonance Quantitative Imaging in the Evaluation of Myocardial Diseases[J].Journal of Medical Information,2019,32(08):8-13.[doi:10.3969/j.issn.1006-1959.2019.08.003]
点击复制

心脏磁共振定量成像评价心肌疾病的应用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年08期
页码:
8-13
栏目:
出版日期:
2019-04-15

文章信息/Info

Title:
Application of Cardiac Magnetic Resonance Quantitative Imaging in the Evaluation of Myocardial Diseases
文章编号:
1006-1959（2019）08-0008-06
作者:
陈智红1; 2; 成官迅1
（1.北京大学深圳医院放射影像科，广东 深圳 518036；2.汕头大学医学院，广东 汕头 515063）
Author(s):
CHEN Zhi-hong1;  2; CHENG Guan-xun1
(1.Department of Radiology,Peking University Shenzhen Hospital,Shenzhen 518036,Guangdong, China;2.Shantou University Medical College,Shantou 515063,Guangdong,China)
关键词:
心脏磁共振; 定量成像; 心肌疾病
Keywords:
Cardiac magnetic resonance; Quantitative imaging; Myocardial disease
分类号:
R542.2
DOI:
10.3969/j.issn.1006-1959.2019.08.003
文献标志码:
A
摘要:
心脏磁共振（CMR）定量成像技术发展迅速，新兴的特征追踪（FT）技术、延迟增强（LGE）的量化技术以及各项绘图技术（T1 mapping、T2 mapping、T2*mapping）无创地提供反映心肌组织表征改变的参数指标，这些定量参数已逐渐成为CMR直接评价各种心肌疾病的稳健生物标志物，在疾病诊断、风险评估、和治疗效果监测等方面具有重要作用。
Abstract:
Cardiac magnetic resonance (CMR) quantitative imaging technology is developing rapidly. Emerging feature tracking (FT) technology, delay enhancement (LGE) quantization technology and various mapping techniques (T1 mapping, T2 mapping, T2*mapping) are provided non-invasively. Parameter parameters reflecting changes in myocardial tissue characterization, these quantitative parameters have gradually become a robust biomarker for CMR to directly evaluate various myocardial diseases, and play an important role in disease diagnosis, risk assessment, and treatment effect monitoring.

参考文献/References:

[1]Gavara J,Rodriguez-Palomares JF,Valente F,et al.Prognostic Value of Strain by Tissue Tracking Cardiac Magnetic Resonance After ST-Segment Elevation Myocardial Infarction[J].JACC Cardiovasc Imaging,2018,11(10):1448-1457. [2]Schneeweis C,Qiu J,Schnackenburg B,et al.Value of additional strain analysis with feature tracking in dobutamine stress cardiovascular magnetic resonance for detecting coronary artery disease[J].J Cardiovasc Magn Reson,2014,16(1):72-79. [3]Romano S,Judd RM,Kim RJ,et al.Feature-Tracking Global Longitudinal Strain Predicts Death in a Multicenter Population of Patients With Ischemic and Nonischemic Dilated Cardiomyopathy Incremental to Ejection Fraction and Late Gadolinium Enhancement[J].JACC Cardiovasc Imaging,2018,11(10):1419-1429. [4]Pi SH,Kim SM,Choi JO,et al.Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction[J].J Cardiovasc Magn Reson,2018,20(1):36-45. [5]Bogarapu S,Puchalski MD,Everitt MD,et al.Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy[J].Pediatr Cardiol,2016,37(4):663-673. [6]Vigneault DM,Te Riele ASJM,James CA,et al.Right ventricular strain by MR quantitatively identifies regional dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy[J].J Magn Reson Imaging,2016,43(5):1132-1139. [7]Nucifora G,Raman KS,Muser D,et al.Cardiac magnetic resonance evaluation of left ventricular functional, morphological, and structural features in children and adolescents vs.young adults with isolated left ventricular non-compaction[J].Int J Cardiol,2017(246):68-73. [8]Nucifora G,Muser D,Morocutti G,et al.Disease-specific differences of left ventricular rotational mechanics between cardiac amyloidosis and hypertrophic cardiomyopathy[J]. Am J Physiol Heart Circ Physiol,2014,307(5):H680-H688. [9]Nakano S,Takahashi M,Kimura F,et al.Cardiac magnetic resonance imaging-based myocardial strain study for evaluation of cardiotoxicity in breast cancer patients treated with trastuzumab: A pilot study to evaluate the feasibility of the method[J]. Cardiol J,2016,23(3):270-280. [10]Schulz-Menger J,Bluemke DA,Bremerich J,et al.Standardized image interpretation and post processing in cardiovascular magnetic resonance:Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing[J].J Cardiovasc Magn Reson,2013(15):35-53. [11]Husser O,Monmeneu JV,Bonanad C,et al.Head-to-head comparison of 1 week versus 6 months CMR-derived infarct size for prediction of late events after STEMI[J].Int J Cardiovasc Imaging,2013,29(7):1499-1509. [12]Garg P,Broadbent DA,Swoboda PP,et al.Extra-cellular expansion in the normal, non-infarcted myocardium is associated with worsening of regional myocardial function after acute myocardial infarction[J].J Cardiovasc Magn Reson,2017,19(1):73-85. [13]Poyhonen P,Kivisto S,Holmstrom M,et al.Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study[J].BMC Cardiovasc Disord,2014(14):110-119. [14]de Jong S,van Veen TA,de Bakker JM,et al.Biomarkers of myocardial fibrosis[J].J Cardiovasc Pharmacol,2011,57(5):522-535. [15]Layland J,Rauhalammi S,Lee MM,et al.Diagnostic Accuracy of 3.0-T Magnetic Resonance T1 and T2 Mapping and T2-Weighted Dark-Blood Imaging for the Infarct-Related Coronary Artery in Non-ST-Segment Elevation Myocardial Infarction[J].J Am Heart Assoc,2017,6(4):e004759. [16]Puntmann VO,Carr-White G,Jabbour A,et al.Native T1 and ECV of Noninfarcted Myocardium and Outcome in Patients With Coronary Artery Disease[J].J Am Coll Cardiol,2018,71(7):766-778. [17]Garg P,Saunders LC,Swift AJ,et al.Role of cardiac T1 mapping and extracellular volume in the assessment of myocardial infarction[J].Anatol J Cardiol,2018,19(6):404-411. [18]Mavrogeni S,Apostolou D,Argyriou P,et al.T1 and T2 Mapping in Cardiology: "Mapping the Obscure Object of Desire"[J].Cardiology,2017,138(4):207-217. [19]Kotanidis CP,Bazmpani MA,Haidich AB,et al.Diagnostic Accuracy of Cardiovascular Magnetic Resonance in Acute Myocarditis: A Systematic Review and Meta-Analysis[J].JACC Cardiovasc Imaging,2018,11(11):1583-1590. [20]Messroghli DR,Moon JC,Ferreira VM,et al.Clinical recommendations for cardiovascular magnetic resonance mapping of T1,T2,T2* and extracellular volume:A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)[J].J Cardiovasc Magn Reson,2017,19(1):75-98. [21]Mavrogeni S,Markousis-Mavrogenis G,Papavasiliou A,et al.Cardiac involvement in Duchenne and Becker muscular dystrophy[J].World J Cardiol,2015,7(7):410-414. [22]Sado DM,White SK,Piechnik SK,et al.Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping[J].Circ Cardiovasc Imaging,2013,6(3):392-398. [23]Torlasco C,Cassinerio E,Roghi A,et al.Role of T1 mapping as a complementary tool to T2* for non-invasive cardiac iron overload assessment[J].PLoS One,2018,13(2):e0192890. [24]Rodrigues JC,Amadu AM,Dastidar AG,et al.Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes[J].Heart,2016,102(20):1671-1679. [25]Araujo-Filho J,Assuncao AJ,Tavares DMM,et al.Myocardial T1 mapping and extracellular volume quantification in patients with left ventricular non-compaction cardiomyopathy[J].Eur Heart J Cardiovasc Imaging,2018,19(8):888-895. [26]Riesenkampff E,Chen CK,Kantor PF,et al.Diffuse Myocardial Fibrosis in Children After Heart Transplantations: A Magnetic Resonance T1 Mapping Study[J].Transplantation,2015,99(12): 2656-2662. [27]Jordan JH,D'Agostino RJ,Hamilton CA,et al.Longitudinal assessment of concurrent changes in left ventricular ejection fraction and left ventricular myocardial tissue characteristics after administration of cardiotoxic chemotherapies using T1-weighted and T2-weighted cardiovascular magnetic resonance[J].Circ Cardiovasc Imaging,2014,7(6):872-879. [28]Tham EB,Haykowsky MJ,Chow K,et al.Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity:relationship to exercise capacity,cumulative dose and remodeling[J].J Cardiovasc Magn Reson,2013(15):48-58. [29]Lurz P,Luecke C,Eitel I,et al.Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial[J].J Am Coll Cardiol,2016,67(15):1800-1811. [30]Bohnen S,Radunski UK,Lund GK,et al.Performance of t1 and t2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure[J].Circ Cardiovasc Imaging,2015,8(6):e003073. [31]Crouser ED,Ono C,Tran T,et al.Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping[J].Am J Respir Crit Care Med,2014,189(1):109-112. [32]Bulluck H,White SK,Rosmini S,et al.T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patients[J].J Cardiovasc Magn Reson,2015(17):73-82. [33]Bonnemains L,Cherifi A,Girerd N,et al.Design of the DRAGET Study: a multicentre controlled diagnostic study to assess the detection of acute rejection in patients with heart transplant by means of T2 quantification with MRI in comparison to myocardial biopsies[J].BMJ Open,2015,5(10):e008963. [34]Anderson LJ,Holden S,Davis B,et al.Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload[J].Eur Heart J,2001,22(23):2171-2179. [35]Pennell DJ,Porter JB,Piga A,et al.Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine[J].Am J Hematol,2015,90(2):91-96. [36]Carrick D,Haig C,Ahmed N,et al.Temporal Evolution of Myocardial Hemorrhage and Edema in Patients After Acute ST-Segment Elevation Myocardial Infarction:Pathophysiological Insights and Clinical Implications[J].J Am Heart Assoc,2016,5(2):e002834.

相似文献/References:

[1]聂洪彪,付 旷.MRI在心肌病诊断和治疗中的应用[J].医学信息,2020,33(07):40.[doi:10.3969/j.issn.1006-1959.2020.07.013]
　NIE Hong-biao,FU Kuang.Application of MRI in Diagnosis and Treatment of Cardiomyopathy[J].Journal of Medical Information,2020,33(08):40.[doi:10.3969/j.issn.1006-1959.2020.07.013]

更新日期/Last Update: 2019-04-15